|
Search
Search through the thousands of lawsuits, complaints and recalls on our site.
|
International Pharmaceuticals, Ltd. Issues a Voluntary Recall of all Viril-Ity-Power (VIP) Tabs, a Product Marketed as a Dietary SupplementDate: 6/12/2008
Reason: it contained a potentially harmful undeclared ingredient, hydroxyhomosildenafil
Distribution: Nationwide
The Food and Drug Administration (FDA) released the following information:
Contact: FOR IMMEDIATE RELEASE -- Bradford, MA - May 29, 2008 - International Pharmaceuticals, Ltd., P.O. Box 5165, Bradford, MA 01835, announced today that it is conducting a voluntary recall of all the company's supplement product sold under the brand name of Viril-Ity-Power (VIP) Tabs, 560mg/serving. International Pharmaceuticals, Ltd. is conducting this recall after being informed by representatives of the Food and Drug Administration (FDA) that lab analysis by FDA of a sample from one lot of the product revealed that it contained a potentially harmful undeclared ingredient, hydroxyhomosildenafil. FDA asserts that this ingredient is an analog of sildenafil. Sildenafil is the active chemical ingredient of an FDA-approved drug used for Erectile Dysfunction (ED) in men to enhance sexual performance. The use of undeclared chemicals pose a threat to consumers because they may harmfully interact with nitrates found in some prescription drugs (such as nitroglycerin) and may lower blood pressure to dangerous levels. Consumers with diabetes, high blood pressure, high cholesterol, or heart disease often take such nitrates. VIP Tabs are sold in retail outlets nationwide and are packaged into 2-capsule blister packs and 8-capsule bottles. Customers who have this product in their possession should stop using it immediately and contact their physician if they have experienced any problems that may be related to taking this product. The Company advises that any unused portions be returned to CB Distributors in Benoit, Wisconsin, in accordance with return instructions/questions obtained by calling (800)-273-4137, Ext. 3. Any adverse events that may be related to the use of this product should be reported to the FDA's MedWatch Program by phone at 1-800-FDA-1088 or by fax at 1-800-FDA-0178 or by mail at MedWatch, HF-2, FDA, 5600 Fishers Lane, Rockville, MD 20852-9787, or online at www.fda.gov/medwatch/report.htm. The Company is working closely with the FDA in the recall process and is taking this voluntary action because it is committed to the quality and integrity of it's products, and is always concerned with the health of persons who may have consumed this product. The Company sincerely regrets any inconvenience to consumers, and is reviewing the procedures and policies of all firms involved with the manufacture of this product to ensure that there will be no subsequent issues with regard to the composition of this product in the future. Other Drugs / Medicines Recalls and Alerts of InterestDate: 7/16/2008 Reason: A sample from product lot 856396A tested positive for a strain of yeast, which could potentially affect immunocompromised patients. Distribution: Nationwide Date: 7/15/2008 Reason: As a precautionary measure, Sage Products announced a voluntary recall of limited lots of 2% Chlorhexidine Gluconate (CHG) Cloth Patient Preoperative Skin Preparation product. Distribution: Nationwide Date: 6/12/2008 Reason: Limited lots of Atrium heparin-coated Hydraglide Thoracic Catheters were manufactured with heparin found to have been contaminated with oversulfated chondroitin sulfate (OSCS) Distribution: Nationwide Date: 8/7/2008 Reason: The product contains potentially harmful, undeclared ingredients. Distribution: Nationwide Date: 8/7/2008 Reason: A sample from one lot of the product revealed that it contained a potentially harmful undeclared ingredient, thio-methisosildenafil. Distribution: Nationwide Date: 6/12/2008 Reason: Taking AZASAN® instead of SOLODYN® presents a health hazard and safety risk to patients |
|
© 2000 - 2008 Copyright. All rights reserved nola3, llc.








